Fibryga

BIOLOGICAL2 trials

Sponsors

Octapharma

Conditions

BleedingCongenital Fibrinogen Deficiency

Unknown Phase

Safety and Efficacy of Fibryga in Congenital Fibrinogen Deficiency

TerminatedNCT03793426

OctapharmaCongenital Fibrinogen Deficiency

Start: 2021-01-28End: 2025-05-14Updated: 2025-06-24

Use of Fibryga, a Fibrinogen Concentrate in Real World: Retrospective Collection of Clinical Data

CompletedNCT04106895

OctapharmaBleeding

Start: 2019-02-21End: 2020-02-10Updated: 2021-05-13

Related Papers

Post-Marketing Observational Study of the Safety and Efficacy of Fibrinogen Concentrate in Congenital Fibrinogen Deficiency in Patients of All Ages

Blood2023-11-02